ACTA1 and cancer: Recently, scRNA‐seq analysis identified a FAP+ α‐SMA+ CAF subset for promoting the TGF‐β1‐driven resistance in immunotherapy.[48] MMT might also play a role in other cancer types, which is yet to be identified and worth for follow‐up studies.